- January 2014: Nortis is awarded pilot study funding from the PATH Malaria Vaccine Initiative (MVI).
2013: Nortis is awarded NIH/NCI, SBIR contract for developing a brain
metastasis assay for drug screening.
2013: Nortis is awarded funding by the PATH Malaria Vaccine Initiative (MVI) to
develop a platform for testing transmission blocking vaccines.
2012: Nortis is awarded a grant from the Bill & Melinda Gates Foundation to
develop a chip for testing anti-malaria drugs.